Epigenetics Market by Product (Kits, Enzymes, Reagents, Instruments); by Application (Oncology, Developmental Biology, Cardiovascular Diseases, Metabolic Diseases, Immunology, Others); by Technology (Methylation, Phosphorylation, Acetylation, Others); by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa): Global Forecasts 2021 To 2027

The Global Epigenetics Market Size was valued at USD 1.3 Bn in 2020 and is expected to reach USD 3.3. Bn by 2027, with a growing CAGR of 13.1 % during the forecast period.

Epigenetics is a study of how DNA interacts with many smaller molecules found within cells that can activate and deactivate genes. Epigenetics deals with how our behavior and environment can cause changes in the working of genes. Epigenetic changes include changes that affect expression and gene activity called phenotypic change. Epigenetic changes can give rise to various diseases such as cancer progression, psychological disorders, etc.

Epigentics Market Size

The driving factors for global epigenetic market include an increase in the prevalence of different types of cancer such as blood cancer, lungs cancer etc and rise in demand for table cancer drugs & treatment. An increase in research activities, government initiatives and funding for R&D, growing application of epigenetics in cancer thrives the growth of the epigenetics market. Moreover, expanding application of epigenetics in non-oncology diseases, development in personalized medicines and demand for targeted therapy is expected to create opportunities for the players in the epigenetics market during the forecast period.

Global Epigenetics Market Segmentation:

By Product

  • Kits
  • Enzymes
  • Reagents
  • Instruments

By Application

  • Oncology
  • Developmental Biology
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Immunology
  • Others

By Technology

  • Methylation
  • Phosphorylation
  • Acetylation
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Based on product, Kits product segment accounted for the highest market share in 2020 due to increase in demand for DNA analysis and its absolute usage in diagnosis

Based on product, the market is segmented include kits, enzymes, reagents and instruments. Kits products is expected to expand market share during forecast period owing to increase in diagnosis of chronic diseases, growth in epigenetic procedures fuels the growth of epigenetic market. Moreover, rise in technological development in epigenetics protocols and growth in number of players drives the growth of epigenetics market.

On the contrary, enzyme segment witness fast market growth with the highest CAGR due to increasing demand for enzyme-based healthcare procedures and their application in diagnosis. zymes plays important role in epigenetic procedures; it is used catalyse epigenetics changes and complex protein. Moreover, its application in building protein study in various pathological procedures boost the growth of enzyme segment in epigenetics market.

Based on application, oncology segment dominated epigenetic market in 2020 and expected to maintain same dominance during forecast period due to increase in prevalence of cancer across the world

Based on application, epigenetics market is segment include oncology, developmental biology, cardiovascular diseases, metabolic diseases and immunology. Oncology segment is expected to dominate the market during forecast period due to increase in use of epigenetics in cancer procedures. Growth in number of R&D centers, growing support from public & private companies for healthcare facilities thrives the growth of the market. Epigenetics have wide application in the treatment and diagnosis of cancer, it helps to learn about cancer cell development and transformation. Moreover, development in epigenetic protocols can be used to select potential biomarkers for cancer, anticancer drugs, and therapies.

According to the survey, on World Cancer Day, the cancer rate reported in 2020 was 50%, emergence of more than 15 million new cancer cases every day. This created awareness among people and government to take imitative for the improving public health by providing healthcare practitioners. This could prevent more than one-third of cancer cases across the globe. According to WHO, 70% of deaths from cancer occur in middle-to-low-income countries due to a lack of awareness regarding an early cancer diagnosis. Owing to this, cancer remains the main driver for the development of new anticancer drugs & therapies that would help to reduce cancer risk.

Based on technology, methylation held the largest market share in 2020 and expected to expand more during forecast period due to increase in demand for high efficiency diagnosis method

Based on technology, epigenetics market segment includes methylation, phosphorylation and acetylation. Methylation technology holds maximum market share due to increase in the need for sensitive and high throughput sequencing method. Methylation has wide application in inhibition of process DNA transcription. Various methods such as southern-based method, allele-specific bisulphite sequencing, PRC-followed by MALDI-TOF MS are widely used for DNA methylation. Moreover, growing advances in technology, use of specific locus-specific DNA methylation, growth in number of research centers is expected to increase the growth of epigenetics market during the forecast period.

Based on geographical region, North America hold the maximum market share in 2020 due to increase in number of cancer cases and rise in research in genetics

Geographically, North America is expected to drive the growth of epigenetics market owing to increase in cancer diseases patients. Rapid development in R&D facilities, healthcare infrastructures, growing strong government support in terms of funding 7 grants for research thrives the growth of the market in North America. Moreover, rise in number of players, increase in demand for protein expression system, increase of epigenetics application in mammalian hormones development boost the growth of epigenetics market. Increase in biopharmaceuticals sales in North America and large spending in healthcare research expected to increase the growth of epigenetic market in coming years.

However, Asia-Pacific anticipate the fast growth in epigenetics market with highest CAGR during the forecast period. This is due to increase in R&D activities, growing government initiatives, and increasing collaborations to expand portfolio in epigenetics products drives the growth of the market in this region.

Company Profiles and Competitive Intelligence

The key players operating in the epigenetics market are:

  • Illumina
  • Thermo Fisher          
  • Diagenode
  • Merck Millipore
  • Abcam
  • Active Motif
  • New England Biolabs
  • Agilent
  • Zymo Research
  • PerkinElmer
  • Bio-Rad
  • Novartis International AG
  • Sigma-Aldrich Corporation
  • Eisai Co. Ltd
  • CellCentric Ltd
  • Chroma Therapeutics Ltd
  • Syndax Pharmaceuticals
  • Oncolys Biopharma Inc.
  • Valirx Plc

The report also provides an in-depth analysis of epigenetics market dynamics such as drivers, restraints, opportunities and challenges


  • Rise in government spending in R&D
  • Increase in product approvals and launches
  • Increase in demand for targeted therapy
  • Increase in technological advances in healthcare
  • Rise in prevalence of cancer


  • Stringent government policies for product approvals
  • High instruments cost hinders the growth of epigenetic market


  • Growing innovation in anti-cancer treatments creates opportunity for the players


  • Resolving the complex molecular basis of clinical phenotypes
  • Difficulties in gaining access to diverse patient's cohorts
  • High patient individualized care cost

COVID-19 Impact on the Epigenetics Market Analysis

Covid-19 has highly affected the industries in terms of growth, economy, health and mental wellbeing of every individual. In this challenging situation, every industry is trying to give best services in terms of quality and safety. Covid-19 has huge impact on the epigenetics market. Covid-19 outbreak has paved the way for researchers to concentrate and develop effective diagnostic test and treatment for coronavirus infection. Moreover, researchers are trying to include epigenetic drugs to cope up with covid infection. This has created opportunity for the scientist and pharmaceutical companies to expand the growth of epigenetics market across world.

Initially, covid-19 pandemic has badly affected healthcare industry as there were restrictions on movement and social distancing led to decrease in number of patients visits in hospitals. Major focus was given on covid infected patients. Epigenetics has wide application in developing and studying the role of virus on human genes and body. This tends to increase in demand for epigenetics tests and diagnosis during pandemic and this led to increase the growth of epigenetics market across the globe.

The report also provides an in-depth analysis of key trends in epigenetics market

  • Sudden increase in demand for virus analysis and drug development to fight against covid-19 have triggered the growth of epigenetics market
  • Increase in government initiatives, development in innovative techniques and demand for diagnostics tools & kits drives the growth of epigenetics market.

The report also provides an in-depth analysis of recent news developments and investments

  • In June 2021, MorphoSys acquired Constellation Pharma at USD 1.2 Bn and aimed to expand their portfolio in epigenetic cancer drugs and to bring expertise in epigenetics.
  • In March 2021, Hologic acquired Diagenode an privately held company at USD 159 Mn to develop its molecular diagnostic business and improving to expand their business across the world.
  • In August 2017, BellBrook Labs announced the launch of drug discovery tool ‘AptaFluor SAH Methyltransferase Assay’ which provide high throughput screening process required in research of epigenetic pathways in cancer and other debilitating diseases.

The unique insights provided by this report also includes the following:

  • In-depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-benchmarking Heat Map
  • Market Trends
  • Covid-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impacts on Epigenetics Market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global epigenetics market was valued at US$ 1.3 Bn in 2020 and is anticipated to reach US$ 3.3 Bn by 2027

The market is estimated to grow at a compound annual growth rate (CAGR) of 13.1 % during the forecast period.

In the base year 2020, North America accounted for about 35% share in the epigenetics market.

High treatment and instrument cost restraint the growth of the global epigenetics market.

As per expert opinions, increase in genomic therapy, rise in prevalence of cancer diseases and growing demand for targeted therapy will the drive the growth of global epigenetics market.

Few key players include, but not limit up to: Abcam, Diagenode, lumina, Thermo Fisher Scientific, Merck, Qiagen, CellCentric Ltd, Zymo research, Chroma Therapeutics Ltd, Syndax Pharmaceuticals, Eisai Co. Ltd, Oncolys Biopharma Inc., Valirx Plc, Novartis International AG and Sigma-Aldrich Corporation

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1.  Introduction
    1. Product Outline
    2. What is Epigenetics Market?
    3. Analysis of Epigenetics Market
    4. Covid -19 Impact
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    6. Technology Overview
  2. Regulatory Landscape for Epigenetics Market
    1. Regulations and Standards
  3. Epigenetics Market by Product
    1. Kits
    2.  Enzymes
    3.  Reagents
    4.  Instruments
  4. Epigenetics Market by Application
    1. Oncology
    2. Developmental Biology
    3.  Cardiovascular Diseases
    4.  Metabolic Diseases
    5.  Immunology
    6.  Others
  5. Epigenetics Market by Technology
    1. Methylation
    2.  Phosphorylation
    3. Acetylation
    4.  Others
  6. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Italy
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Latin America
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    5. Middle East & Africa
      1. South Africa
      2. Rest of Africa
  7. Key Strategic Insights
  8. Market Analysis
    1. New Applications
    2. Emerging Technologies
    3. Opportunity Mapping
    4. Critical Success Factors
  9. Key Market Trends / Recent Developments
  10. Competitive Scenario
    1. Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product Launches
    5. Ranking of Key Players
  11. Key global players
    1. Illumina
    2. Thermo Fisher          
    3. Diagenode
    4. QIAGEN
    5. Merck Millipore
    6. Abcam
    7. Active Motif
    8. New England Biolabs
    9. Agilent
    10. Zymo Research
    11. PerkinElmer
    12. Bio-Rad
    13. Novartis International AG
    14. Sigma-Aldrich Corporation
    15. Eisai Co. Ltd

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization